BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation-Reference-Cited by-同舟云学术

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

Published:2013-01-31 Issue:3 Volume:7 Page:567-579
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Stordal Britta,Timms Kirsten,Farrelly Angela,Gallagher Danielle,Busschots Steven,Renaud Mickaël,Thery Julien,Williams Deborah,Potter Jennifer,Tran Thanh,Korpanty Greg,Cremona Mattia,Carey Mark,Li Jie,Li Yang,Aslan Ozlem,O'Leary John J.,Mills Gordon B.,Hennessy Bryan T.

Funder

Irish Cancer Society

Science Foundation Ireland/Health Research Board Translational Research Award (BTH)

Conquer Cancer Foundation (CCF)

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference74 articles.

1. Anonymous 2012 A2780 ECACC Datasheet http://www.hpacultures.org.uk

2. Anonymous 2012 CRL-1978™ (ES-2) ATCC Datasheet http://www.lgcstandards-atcc.org

3. Anonymous 2012 HTB-75™ (CAOV3) ATCC Datasheet http://www.lgcstandards-atcc.org

4. Anonymous 2012 HTB-78™ (SW626) ATCC Datasheet http://www.lgcstandards-atcc.org/

5. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian breast cancer study group;Anonymous;British Journal of Cancer,2000

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches;Translational Oncology;2024-12

2. Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM;Nature Communications;2024-08-14

3. Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models;Molecular Biology Reports;2024-06-28

4. Epigenetic editing of BRCA1 promoter increases cisplatin and olaparib sensitivity of ovarian cancer cells;Epigenetics;2024-05-26

5. Pan-cancer Analysis of Homologous Recombination Deficiency in Cell Lines;2024-05-20